Cell death following the loss of ADAR1 mediated A-to-I RNA editing is not effected by the intrinsic apoptosis pathway

被引:0
|
作者
Carl R. Walkley
Benjamin T. Kile
机构
[1] St. Vincent’s Institute of Medical Research,Department of Medicine, St. Vincent’s Hospital, Melbourne Medical School
[2] University of Melbourne,Mary MacKillop Institute for Health Research
[3] Australian Catholic University,Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute
[4] Monash University,undefined
[5] University of Adelaide,undefined
来源
Cell Death & Disease | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Modifications of RNA, collectively termed as the epitranscriptome, are widespread, evolutionarily conserved and contribute to gene regulation and protein diversity in healthy and disease states. There are >160 RNA modifications described, greatly exceeding the number of modifications to DNA. Of these, adenosine-to-inosine (A-to-I) RNA editing is one of the most common. There are tens of thousands of A-to-I editing sites in mouse, and millions in humans. Upon translation or sequencing an inosine base is decoded as guanosine, leading to A-to-G mismatches between the RNA and DNA. Inosine has different base pairing properties to adenosine and as a result editing not only alters the RNA code but can also change the RNA structure. In mammals A-to-I editing is performed by ADAR1 and ADAR2. A feature of murine loss of function ADAR1 alleles is cell death and a failure to survive embryogenesis. Adar1−/− and editing deficient (Adar1E861A/E861A) mice die between E11.75–13.5 of failed hematopoiesis. Strikingly this phenotype is rescued by the deletion of the cytosolic dsRNA sensor MDA5 or its downstream adaptor MAVS, a mechanism conserved in human and mouse. Current literature indicates that the loss of ADAR1 leads to cell death via apoptosis, yet this has not been genetically established. We report that blockade of the intrinsic (mitochondrial) apoptosis pathway, through the loss of both BAK and BAX, does not rescue or modify the cellular phenotype of the fetal liver or extend the lifespan of ADAR1 editing deficient embryos. We had anticipated that the loss of BAK and BAX would rescue, or at least significantly extend, the gestational viability of Adar1E861A/E861A embryos. However, the triple mutant Adar1E861A/E861ABak−/−Bax−/− embryos that were recovered at E13.5 were indistinguishable from the Adar1E861A/E861A embryos with BAK and BAX. The results indicate that cell death processes not requiring the intrinsic apoptosis pathway are triggered by MDA5 following the loss of ADAR1.
引用
收藏
相关论文
共 50 条
  • [31] Emerging role of the RNA-editing enzyme ADAR1 in stem cell fate and function
    Lu, Di
    Lu, Jianxi
    Liu, Qiuli
    Zhang, Qi
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [32] Induction of protein translation by ADAR1 within living cell nuclei is not dependent on RNA editing
    Herbert, A
    Wagner, S
    Nickerson, JA
    MOLECULAR CELL, 2002, 10 (05) : 1235 - 1246
  • [33] ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner
    Liu, Qi
    Huang, Chen-Song
    Chen, Siyun
    Zhu, Ying-Qin
    Huang, Xi-Tai
    Zhao, Guang-Yin
    Xu, Qiong-Cong
    Shi, Yin-Hao
    Li, Wen
    Wang, Ruizhi
    Yin, Xiao-Yu
    CELL PROLIFERATION, 2024, 57 (10)
  • [34] ADAR1-mediated RNA editing promotes B cell lymphomagenesis
    Pecori, Riccardo
    Ren, Weicheng
    Pirmoradian, Mohammad
    Binder, Marco
    Papavasiliou, Nina
    Wang, Xianhuo
    Liu, Dongbing
    Berglund, Mattias
    Li, Wei
    Tasakis, Rafail Nikolaos
    Di Giorgio, Salvatore
    Ye, Xiaofei
    Li, Xiaobo
    Wu, Kui
    Helm, Dominic
    Arnold, Annette
    Wust, Sandra
    Schneider, Martin
    Selvasaravanan, Karthik-Devi
    Fuell, Yvonne
    Stafforst, Thorsten
    Amini, Rose-Marie
    Sonnevi, Kristina
    Enblad, Gunilla
    Sander, Birgitta
    Wahlin, Bjorn Engelbrekt
    Zhang, Huilai
    Papavasiliou, F. Nina
    Pan-Hammarstrom, Qiang
    ISCIENCE, 2023, 26 (06)
  • [35] RNA editing enzyme ADAR1 accelerates normal hematopoiesis cell cycle by regulation microRNA biogenesis
    Jiang, Qingfei
    Zipeto, Maria Anna
    Delos Santos, Nathan
    Morris, Sheldon
    Jamieson, Catriona
    CANCER RESEARCH, 2017, 77
  • [36] RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis
    Jiang, Qingfei
    Zipeto, Maria A.
    Delos Santos, Nathaniel
    Leu, Heather
    Isquith, Jane
    Atien, Etienne
    Jamieson, Catriona
    BLOOD, 2016, 128 (22)
  • [37] Aberrant a-to-I RNA Editing and Prognostic Impact of Adar in Multiple Myeloma Patients with 1q Amplification
    Lagana, Alessandro
    Perumal, Deepak
    Leshchenko, Violetta V.
    Kuo, Pei-Yu
    Kidd, Brian
    Keats, Jonathan J.
    Derome, Mary
    Yesil, Jennifer
    Auclair, Daniel
    Madduri, Deepu
    Chari, Ajai
    Cho, Hearn Jay
    Barlogie, Bart
    Jagannath, Sundar
    Dudley, Joel
    Parekh, Samir
    BLOOD, 2016, 128 (22)
  • [38] Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma
    Lagana, Alessandro
    Leshchenko, Violetta
    Melnekoff, David
    Beno, Itai
    Perumal, Deepak
    Keats, Jonathan
    DeRome, Mary
    Yesil, Jennifer
    Auclair, Daniel
    Madduri, Deepu
    Chari, Ajai
    Cho, Hearn Jay
    Barlogie, Bart
    Jagannath, Sundar
    Dudley, Joel
    Parekh, Samir
    BLOOD, 2017, 130
  • [39] Enhanced Radiosensitivity of Esophagus Cancer through Loss of ADAR1 and Cell Apoptosis via NF-κB Signaling Pathway
    Sun, L.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E261 - E261
  • [40] Elevated cancer-intrinsic type I interferon signaling confers a dependency on the RNA editor ADAR1
    Gardino, Alexandra K.
    Collins, Cindy
    Lynes, Maureen S.
    Boriack-Sjodin, P. Ann
    Copeland, Robert A.
    Ribich, Scott A.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)